Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management
Type and search

All notices

Notice of Annual General Meeting 2020

04.05.2020

SHARE CAPITAL INCREASE REGISTERED

06.04.2020

PRIVATE PLACEMENT TOWARDS BOMI FRAMROZE – PRIMARY INSIDER DISCLOSURE

23.03.2020

EU DISTRIBUTION AGREEMENT SIGNED WITH PRINOVA EUROPE FOR MARINE BRANDED PRODUCTS RANGE

17.03.2020

MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER IN HOFSETH BIOCARE ASA

26.02.2020

Fourth Quarter 2019 Financial Report

07.02.2020

Signs new working capital credit line of NOK 37m

04.02.2020

MANDATORY NOTIFICATION OF TRADE

01.01.2020

ATLANTIC SAPPHIRE AS AND HOFSETH BIOCARE ASA SIGN LOI TO ESTABLISH A JOINT VENTURE IN MIAMI, US

01.11.2019

Third Quarter 2019 Financial Report

01.11.2019

Previous
6 7 8
9
10 11 12
...
30
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management

Copyright 2021 Hofseth BioCare ASA
Privacy cookies